Charles A. Reidy

Varespladib (A-002), a Secretory Phospholipase A2 Inhibitor, Reduces Atherosclerosis and Aneurysm Formation in ApoE− / − Mice

Heather Fraser, Colin Hislop, Robert Christie et al. · Journal of Cardiovascular Pharmacology · 2009 · 87 citations

Vascular Disease, Aneurysm Formation, Lipid Peroxidation +19

ATP causes retinal pericytes to contract in vitro

Arup Das, Robert N. Frank, Mark L. Weber et al. · Experimental Eye Research · 1988 · 75 citations

Photoreceptor Cell, Molecular Physiology, Retina +10

A comparison of male rat and human urinary proteins: Implications for human resistance to hyaline droplet nephropathy

Michael J. Olson, John T. Johnson, Charles A. Reidy · Toxicology and Applied Pharmacology · 1990 · 73 citations

Human Resistance, Urology, Renal Function +10

Discovery of 6-(4-{[5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl]methoxy}piperidin-1-yl)-1-methyl-1<i>H</i>-indole-3-carboxylic Acid: A Novel FXR Agonist for the Treatment of Dyslipidemia

Michaël Génin, Ana B. Bueno, Javier Agejas Francisco et al. · Journal of Medicinal Chemistry · 2015 · 57 citations · Full text

Pharmaceutical Science, Selective Fxr Agonist, Farnesoid X Receptor +18

Genetic ablation of IRAK4 kinase activity inhibits vascular lesion formation

Mark D. Rekhter, Kirk A. Staschke, Thomas Estridge et al. · Biochemical and Biophysical Research Communications · 2008 · 42 citations

Signal Transduction, Angiogenesis, Genetic Ablation +7